BIOCONNSEBiocon Limited· PharmaceuticalsMediumNeutral
Announced Tue, 8 Apr · 16:24 IST

Kiran Mazumdar Shaw has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Ownership Changes View source PDF

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Promoter Kiran Mazumdar Shaw has filed a disclosure with the exchange under Regulation 31(4) of the SEBI Takeover Regulations, 2011. This is a mandatory yearly filing where promoters disclose details of any encumbrance (pledge/lien) on their shares and declare their intentions regarding further acquisition of shares under the creeping acquisition framework. The announcement does not specify whether the disclosure indicates any new pledge, pledge release, or intent to acquire additional shares.

Likely market impact

This appears to be a routine regulatory compliance filing with no immediate material impact on shareholders. The actual content of the disclosure (which would clarify any encumbrance changes or acquisition intentions) was not provided in the headline and would need to be reviewed separately for any meaningful signal.